Pfizer Recalls All of Its Sickle Cell Disease Treatment Over Safety Concerns
Pfizer is withdrawing all of its sickle cell disease drug, Oxbryta, worldwide because of safety concerns. Pfizer ( PFE) shares declined Thursday after the drug maker recalled all lots of its sickle cell disease medicine worldwide because of concerns it could lead to severe pain and possibly death in patients.
A man and woman, both with sickle cell, share what their experience was like finding love, and what prospective partners need ...
September is Sickle Cell Awareness month.While the month itself is almost over, patients living with the disease face a daily ...
Sickle Cell Disease Treatment Centers Act. If passed, this bicameral bill would significantly improve patients’ access to ...
Sickle cell disease (SCD) is a group of painful and life-threatening genetic disorders that affect hemoglobin, the major ...
Rochester, N.Y. The classmates of a young woman who passed away from sickle cell disease are giving back in her memory.
Gene therapy for sickle cell disease remains a tough business model — and may never work, @adamfeuerstein writes.
The RUBY Trial is showing promise in treating patients fighting sickle cell disease, and Ohio is setting a national standard for addressing health inequities.
They symbolize the crescent-shaped blood cells caused by the genetic mutation of sickle cell disease. Art therapist Emily ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback